I. Simonitsch et al., NPM ALK GENE FUSION TRANSCRIPTS IDENTIFY A DISTINCT SUBGROUP OF NULL TYPE KI-1 POSITIVE ANAPLASTIC LARGE-CELL LYMPHOMAS/, British Journal of Haematology, 92(4), 1996, pp. 866-871
The chromosomal aberration t(2;5) resulting in the juxtaposition of NP
M and ALK genes is a well-known feature of several Ki-1(+) anaplastic
large cell lymphomas (ALCL) of the T-cell type. However, conflicting r
esults have been reported concerning the presence of this gene rearran
gement in other ALCL and Hodgkin's disease (HD), respectively. We perf
ormed NPM/ALK RT-PCR on 14 cases of ALCL expressing distinct myelomono
cytic markers, e.g, CD11c, CD13, CD14 or CD68, but neither T-cell nor
B-cell associated antigens (null cell phenotype). The specific translo
cation was found exclusively in six childhood tumours previously diagn
osed as malignant histiocytosis (MH), whereas all adult lymphomas (thr
ee ALCL without characteristics of MH, three secondary ALCL following
HD) and two paediatric cases of secondary ALCL following HD did not sh
ow NPM/ALK gene fusion products. By Southern blotting, the status of T
-cell receptor (TCR) and immunoglobulin heavy chain genes (IgH) were i
nvestigated; two patients with initially diagnosed MW had the TCR delt
a-chain gene rearranged (D delta 2-D delta 3 and V delta 1-J delta 1,
respectively). IgH rearrangements were detected in only one patient wi
th secondary ALCL. Our data indicate a high association of previously
diagnosed MH and NPM/ALK gene rearrangements. In one case, this specif
ic translocation was demonstrated at an early stage of development; in
another, a mature TCR delta-chain gene rearrangement was detected. Th
ese data support the hypothesis of a lymphoid origin of this subgroup
of Ki-l positive ALCL previously diagnosed as MH.